Therefore, as mutational inactivation of SDHx genes is associated with increased tumor aggressiveness and metastatic burden [30, 51], it is reasonable to envision a role for GPT2 in promoting metastatic potential of SDH-deficient tumors, in addition to the direct control of cell proliferative potential. The gene discussed is GPT2; the disease is neoplasm.